Revelation Biosciences
revelation developing innovative therapeutics to address unmet needs | Revelation Biosciences
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
1 of 18
Related slides by other companies
AN2 Therapeutics
IPO
March 2022
an therapeutics developing treatments for rare chronic and serious infectious diseases with high unmet needs | AN2 Therapeutics
AN2 Therapeutics
IPO
March 2022
an therapeutics developing treatments for rare chronic and serious infectious diseases with high unmet needs | AN2 Therapeutics
Aravive
Investor Presentation
September 2022
developing transformative targeted cancer therapeutics | Aravive
Aravive
Investor Presentation
September 2022
developing transformative targeted cancer therapeutics | Aravive
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights